Skeletal muscle mass as a predictor of mortality in the elderly population

A U-shaped relationship between body mass index (BMI) and mortality has been reported. However,controversy exists as to whether skeletal muscle mass affects mortality in healthy older adults. We evaluated the independentassociation of BMI or appendicular skeletal muscle mass (ASM) with mortality in elderly people. Methods: A total of 4,261 consecutive subjects older than 65 years who underwent health examinations at Seoul NationalUniversity Gangnam Center between 2005 and 2009 were included in the analysis. ASM, ASM/height² and ASM/weight wereestimated by bioelectrical impedance analysis. Sarcopenia was defined as a relative skeletal muscle mass of 1-2 SD below (class I)or more than 2 SD below (class II) the gender-specific mean for healthy young adults. BMI was grouped into five groups (A-E). Results: During the follow-up period (27.2 ± 13.5 months), 63 subjects died. The subjects who died were significantly older andhad a male predominance, increased levels of inflammatory markers and poor nutritional statuses. In a fully adjusted Coxproportional hazards model, BMI was not associated with mortality. However, class I sarcopenia (HR 2.11, 95% CI 1.17-3.79) andclass II sarcopenia (HR 3.47, 95% CI 1.62-7.43), defined by ASM/height², were related to all-cause mortality. This association wasnot observed when sarcopenia was defined by ASM/weight. Class II sarcopenia defined by ASM/height² was associated withcancer-related mortality (HR 5.73, 95% CI 2.22-14.78), but not with cardiovascular mortality (HR 1.56, 95% CI 0.17-14.27). Conclusions: This study indicates that lower skeletal muscle mass is a risk marker for cancer-related and all-cause mortality inKorean elderly people. (Korean J Med 2013;85:167-173)